Last reviewed · How we verify
Pred-Gati-Brom
Pred-Gati-Brom is a fixed-dose combination ophthalmic drop containing a corticosteroid, a GABA agonist, and a bromide salt that reduces intraocular pressure and inflammation in the eye.
Pred-Gati-Brom is a fixed-dose combination ophthalmic drop containing a corticosteroid, a GABA agonist, and a bromide salt that reduces intraocular pressure and inflammation in the eye. Used for Post-operative inflammation and infection following ocular surgery.
At a glance
| Generic name | Pred-Gati-Brom |
|---|---|
| Also known as | LessDrops |
| Sponsor | Carolina Eyecare Physicians, LLC |
| Drug class | Fixed-dose combination ophthalmic agent (corticosteroid + fluoroquinolone + bromide salt) |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | FDA-approved |
Mechanism of action
The prednisolone component provides anti-inflammatory effects by suppressing immune responses in ocular tissues. Gatifloxacin is a fluoroquinolone antibiotic that provides antimicrobial coverage. Bromide may contribute to osmotic effects or have additional therapeutic properties in the formulation. Together, these agents address multiple pathways in ocular inflammation and pressure regulation.
Approved indications
- Post-operative inflammation and infection following ocular surgery
Common side effects
- Ocular irritation
- Conjunctival hyperemia
- Transient vision disturbance
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |